Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Type-2 inflammation: a key treatable trait associated with lung function decline in chronic airways disease

Petousi N. et al, (2024), Thorax

Computed Cardiopulmonography for the Detection of Early Smoking-Related Changes in the Lungs of Young Individuals Who Smoke.

Redmond JL. et al, (2024), Chest

Effects of sleep disturbance on dyspnoea and impaired lung function following hospital admission due to COVID-19 in the UK: a prospective multicentre cohort study

Jackson C. et al, (2023), The Lancet Respiratory Medicine, 11, 673 - 684

Determinants of recovery from post-COVID-19 dyspnoea: analysis of UK prospective cohorts of hospitalised COVID-19 patients and community-based controls

Zheng B. et al, (2023), The Lancet Regional Health - Europe, 29, 100635 - 100635

The Lancet COPD Commission: broader questions remain

Petousi N. et al, (2023), The Lancet, 401, 1569 - 1570

Prevalence of physical frailty, including risk factors, up to 1 year after hospitalisation for COVID-19 in the UK: a multicentre, longitudinal cohort study

McAuley HJC. et al, (2023), eClinicalMedicine, 57, 101896 - 101896

Persistence of inflammatory and vascular mediators 5 months after hospitalization with COVID-19 infection

Melhorn J. et al, (2023), Frontiers in Medicine, 10

Toward a Predict and Prevent Approach in Obstructive Airway Diseases.

Couillard S. et al, (2023), J Allergy Clin Immunol Pract

Editorial: Physiological phenotyping in respiratory diseases: New approaches.

King GG. et al, (2023), Frontiers in physiology, 14

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

Liew F. et al, (2023), eBioMedicine, 87, 104402 - 104402

Altered lung physiology in two cohorts after COVID-19 infection as assessed by computed cardiopulmonography

Magor-Elliott SRM. et al, (2022), Journal of Applied Physiology, 133, 1175 - 1191

The Lognormal Lung: A new approach to quantifying lung inhomogeneity in COPD

Smith NMJ. et al, (2022), Frontiers in Physiology, 13

Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study

Evans RA. et al, (2022), The Lancet Respiratory Medicine, 10, 761 - 775

Sub‐stratification of type‐2 high airway disease for therapeutic decision‐making: A ‘bomb’ (blood eosinophils) meets ‘magnet’ ( FeNO ) framework

Couillard S. et al, (2022), Respirology, 27, 573 - 577

Proteomic Biomarkers of the Apnea Hypopnea Index and Obstructive Sleep Apnea: Insights into the Pathophysiology of Presence, Severity, and Treatment Response

Cederberg KLJ. et al, (2022), International Journal of Molecular Sciences, 23, 7983 - 7983

MONITORING THE EFFECT OF THERAPEUTIC INTERVENTIONS IN ASTHMA USING A NOVEL MEASURE OF LUNG INHOMOGENEITY

Alamoudi A. et al, (2022), CHEST, 161, 429A - 429A

THE ADDITIVE EFFECT OF AWAKE PRONE POSITIONING ON OXYGEN REQUIREMENTS AND SATURATIONS IN PATIENTS WITH COVID-19 ESTABLISHED ON CPAP

SMITH O. et al, (2022), CHEST, 161, 454A - 454A

Divergent trajectories of antiviral memory after SARS-CoV-2 infection

Tomic A. et al, (2022), Nature Communications, 13

Identifying putative ventilation-perfusion distributions in COVID-19 pneumonia.

Xu H. et al, (2022), PloS one, 17

Persistence of inflammatory and vascular damage mediators 5 months after acute COVID-19

Petousi N. et al, (2022), EUROPEAN RESPIRATORY JOURNAL, 60

Load More

Include forthcoming?